Skip to main content
Donate | Join

News / Articles

FDA approves first generic naloxone nasal spray to treat opioid overdose

Published on 4/23/2019

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm636333.htm

 
Return to Previous Page

Promoting Health.
Preventing Disease.
Protecting South Dakotans.

Stay Informed
Sign up to receive updates and news from the South Dakota Public Health Association.

Join Our Mailing List

Stay Connected